CAMP4 THERAPEUTICS CORPORATION CAMP
3.83 USD +0.06 (+1.46%)
At closeNov 3, 2026, 4:01 PM EST
3.83 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
3.79 Day range 4.00
2.90 52-week range 7.75
- YTD
- -37.52%
- 1 year
- -2.79%
Analyst view
Price target (mean) 19.91 +419.8% upside
Now 3.83
- Target (low)
- 17.00
- Target (mean)
- 19.91
- Target (high)
- 22.63
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy2
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.91409 | -1.22 – -0.74 | 0.00 | 0.0% | 20.75K | 0.0% | 3 |
| Next quarter | -0.70333 | -0.77 – -0.65 | 0.00 | 0.0% | 41.50K | 0.0% | 3 |
| Current year | -4.77 | -6.21 – -3.73 | 0.00 | 0.0% | 27.67K | 0.0% | 4 |
| Next year | -2.86 | -3.07 – -2.50 | -4.77 | +40.1% | 83.25K | +200.9% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 5, 2024 | William Blair | Initiated | — | Outperform |
| Nov 5, 2024 | Leerink Partners | Initiated | — | Outperform |
| Nov 5, 2024 | JP Morgan | Initiated | — | Overweight |
| Nov 5, 2024 | Piper Sandler | Initiated | — | Overweight |